N85.0

Clinical Causes: Chronic exposure to high levels of estrogen without progesterone balance Hormonal imbalance due to conditions like polycystic ovary syndrome (PCOS) Obesity, which can increase estrogen levels Hormone replacement therapy that involves estrogen alone Tamoxifen therapy used in breast cancer treatment Anovulatory cycles, where ovulation does not occur Perimenopause or menopause-related hormonal changes

Key Symptoms: Abnormal uterine bleeding, such as heavy periods or bleeding between periods Irregular menstrual cycles Pelvic pain or discomfort (less common) Prolonged or excessive menstrual flow Spotting after menopause Pelvic pressure or fullness in some cases

Diagnosis Path: Diagnosis of endometrial hyperplasia typically involves a combination of medical history review, physical examination, and diagnostic procedures. Key steps include: - Transvaginal ultrasound to assess endometrial thickness - Endometrial biopsy to obtain tissue samples for microscopic examination - Curettage or dilation and curettage (D&C) to remove and evaluate tissue if necessary - Additional imaging tests or hysteroscopy in certain cases to visualize the uterine cavity more clearly Medical professionals analyze tissue samples to distinguish between benign hyperplasia and potential precancerous or cancerous changes.

Treatment Protocols: Treatment options depend on the severity of hyperplasia and whether atypical cells are present. Common approaches include: - Hormonal therapy with progestins to counterbalance estrogen effects and induce regression of the endometrial lining - Regular monitoring through ultrasound and biopsies for mild cases - Surgical procedures, such as hysterectomy, for severe or atypical hyperplasia, particularly if cancer risk is high - Addressing underlying causes, such as weight management for obesity or modifying hormone therapy Early detection and management are vital to prevent progression to endometrial cancer, especially in cases with atypical hyperplasia.